keyword
https://read.qxmd.com/read/38669943/production-of-native-recombinant-proteins-using-a-novel-split-intein-affinity-technology
#21
JOURNAL ARTICLE
Robert Clifford, Susanna Lindman, Jie Zhu, Ethan Luo, Jared Delmar, Yeqing Tao, Kuishu Ren, Abigail Lara, Corinne Cayatte, Patrick McTamney, Ellen O'Connor, Johan Öhman
Affinity tags are frequently engineered into recombinant proteins to facilitate purification. Although this technique is powerful, removal of the tag is desired because the tag can interfere with biological activity and can potentially increase the immunogenicity of therapeutic proteins. Tag removal is complex, as it requires adding expensive protease enzymes. To overcome this limitation, split intein based affinity purification systems have been developed in which a CC -intein tag is engineered into a protein of interest for binding to a NC -intein peptide ligand fixed to a chromatographic support...
April 12, 2024: Journal of Chromatography. A
https://read.qxmd.com/read/38669336/vagus-nerve-stimulation-modulates-distinct-acetylcholine-receptors-on-b-cells-and-limits-the-germinal-center-response
#22
JOURNAL ARTICLE
Izumi Kurata-Sato, Ibrahim T Mughrabi, Minakshi Rana, Michael Gerber, Yousef Al-Abed, Barbara Sherry, Stavros Zanos, Betty Diamond
Acetylcholine is produced in the spleen in response to vagus nerve activation; however, the effects on antibody production have been largely unexplored. Here, we use a chronic vagus nerve stimulation (VNS) mouse model to study the effect of VNS on T-dependent B cell responses. We observed lower titers of high-affinity IgG and fewer antigen-specific germinal center (GC) B cells. GC B cells from chronic VNS mice exhibited altered mRNA and protein expression suggesting increased apoptosis and impaired plasma cell differentiation...
April 26, 2024: Science Advances
https://read.qxmd.com/read/38665833/design-synthesis-in-vitro-and-in-silico-evaluation-of-indole-based-tetrazole-derivatives-as-putative-anti-breast-cancer-agents
#23
JOURNAL ARTICLE
Kamalpreet Kaur, Harkomal Verma, Prabhakar Gangwar, Monisha Dhiman, Vikas Jaitak
A series of new indole-tetrazole derivatives were designed and synthesized to develop potential anti-breast cancer agents. The compounds exhibited in vitro anti-proliferative activity against ER-α positive T-47D (IC50 = 3.82-24.43 μM), MCF-7 (IC50 = 3.08-22.65 μM), and ER-α negative MDA-MB-231 (IC50 = 7.69-19.4 μM) human breast cancer cell lines. Compounds 5d and 5f displayed significant anti-proliferative activity compared to bazedoxifene (IC50 = 14.23 ± 0.68 μM), with IC50 values of 10...
April 24, 2024: RSC medicinal chemistry
https://read.qxmd.com/read/38665159/probing-the-crl4-dcaf12-interactions-with-magea3-and-cct5-di-glu-c-terminal-degrons
#24
JOURNAL ARTICLE
Germanna Lima Righetto, Yanting Yin, David M Duda, Victoria Vu, Magdalena M Szewczyk, Hong Zeng, Yanjun Li, Peter Loppnau, Tony Mei, Yen-Yen Li, Alma Seitova, Aaron N Patrick, Jean-Francois Brazeau, Charu Chaudhry, Dalia Barsyte-Lovejoy, Vijayaratnam Santhakumar, Levon Halabelian
Damaged DNA-binding protein-1 (DDB1)- and CUL4-associated factor 12 (DCAF12) serves as the substrate recognition component within the Cullin4-RING E3 ligase (CRL4) complex, capable of identifying C-terminal double-glutamic acid degrons to promote the degradation of specific substrates through the ubiquitin proteasome system. Melanoma-associated antigen 3 (MAGEA3) and T-complex protein 1 subunit epsilon (CCT5) proteins have been identified as cellular targets of DCAF12. To further characterize the interactions between DCAF12 and both MAGEA3 and CCT5, we developed a suite of biophysical and proximity-based cellular NanoBRET assays showing that the C-terminal degron peptides of both MAGEA3 and CCT5 form nanomolar affinity interactions with DCAF12 in vitro and in cells...
April 2024: PNAS Nexus
https://read.qxmd.com/read/38664585/a-dietary-commensal-microbe-enhances-antitumor-immunity-by-activating-tumor-macrophages-to-sequester-iron
#25
JOURNAL ARTICLE
Garima Sharma, Amit Sharma, Inhae Kim, Dong Gon Cha, Somi Kim, Eun Seo Park, Jae Gyun Noh, Juhee Lee, Ja Hyeon Ku, Yoon Ha Choi, JungHo Kong, Haena Lee, Haeun Ko, Juhun Lee, Anna Notaro, Seol Hee Hong, Joon Haeng Rhee, Sang Geon Kim, Cristina De Castro, Antonio Molinaro, Kunyoo Shin, Sanguk Kim, Jong Kyoung Kim, Dipayan Rudra, Sin-Hyeog Im
Innate immune cells generate a multifaceted antitumor immune response, including the conservation of essential nutrients such as iron. These cells can be modulated by commensal bacteria; however, identifying and understanding how this occurs is a challenge. Here we show that the food commensal Lactiplantibacillus plantarum IMB19 augments antitumor immunity in syngeneic and xenograft mouse tumor models. Its capsular heteropolysaccharide is the major effector molecule, functioning as a ligand for TLR2...
April 25, 2024: Nature Immunology
https://read.qxmd.com/read/38661304/structure-based-rational-and-general-strategy-for-stabilizing-single-chain-t-cell-receptors-to-enhance-affinity
#26
JOURNAL ARTICLE
Jia-Ling Zou, Kai-Xiang Chen, Xiao-Juan Wang, Zheng-Chang Lu, Xian-Hui Wu, Yun-Dong Wu
The T-cell receptor (TCR) is a crucial molecule in cellular immunity. The single-chain T-cell receptor (scTCR) is a potential format in TCR therapeutics because it eliminates the possibility of αβ-TCR mispairing. However, its poor stability and solubility impede the in vitro study and manufacturing of therapeutic applications. In this study, some conserved structural motifs are identified in variable domains regardless of germlines and species. Theoretical analysis helps to identify those unfavored factors and leads to a general strategy for stabilizing scTCRs by substituting residues at exact IMGT positions with beneficial propensities on the consensus sequence of germlines...
April 25, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38659938/directed-evolution-based-discovery-of-ligands-for-in-vivo-restimulation-of-car-t-cells
#27
Leyuan Ma, Ranjani Ramasubramanian, Naveen K Mehta, Benjamin Cossette, Duncan M Morgan, Ina Sukaj, Elisa Bergaggio, Stephan Kadauke, Regina M Myers, Luca Paruzzo, Guido Ghilardi, Tomasz M Grzywa, Austin Cozzone, Stephen J Schuster, Noelle Frey, Libin Zhang, Parisa Yousefpour, Wuhbet Abraham, Heikyung Suh, Marco Ruella, Stephan A Grupp, Roberto Chiarle, K Dane Wittrup, Darrell J Irvine
Chimeric antigen receptor (CAR) T cell therapy targeting CD19 elicits remarkable clinical efficacy in B-cell malignancies, but many patients relapse due to failed expansion and/or progressive loss of CAR-T cells. We recently reported a strategy to potently restimulate CAR-T cells in vivo , enhancing their functionality by administration of a vaccine-like stimulus comprised of surrogate peptide ligands for a CAR linked to a lymph node-targeting amphiphilic PEG-lipid (termed CAR-T-vax). Here, we demonstrate a general strategy to generate and optimize peptide mimotopes enabling CAR-T-vax generation for any CAR...
April 17, 2024: bioRxiv
https://read.qxmd.com/read/38657864/sorl1-is-a-receptor-for-tau-that-promotes-tau-seeding
#28
JOURNAL ARTICLE
Joanna M Cooper, Aurelien Lathuiliere, Enming J Su, Yuyu Song, Daniel Torrente, Youhwa Jo, Nicholas Weinrich, Jennifer Diaz Sales, Mary Migliorini, Thomas H Sisson, Daniel A Lawrence, Bradley T Hyman, Dudley K Strickland
Sortilin-related receptor 1 (SORL1) is an intracellular sorting receptor genetically implicated in Alzheimer's disease (AD) that impacts amyloid precursor protein trafficking. The objective of these studies was to test the hypothesis that SORL1 binds tau, modulates its cellular trafficking and impacts the aggregation of cytoplasmic tau induced by pathological forms of tau. Using surface plasmon resonance measurements, we observed high-affinity binding of tau to SORL1 and the vacuolar protein sorting 10 (VPS10) domain of SORL1...
April 22, 2024: Journal of Biological Chemistry
https://read.qxmd.com/read/38651407/factors-governing-b-cell-recognition-of-autoantigen-and-function-in-type-1-diabetes
#29
REVIEW
Lindsay E Bass, Rachel H Bonami
Islet autoantibodies predict type 1 diabetes (T1D) but can be transient in murine and human T1D and are not thought to be directly pathogenic. Rather, these autoantibodies signal B cell activity as antigen-presenting cells (APCs) that present islet autoantigen to diabetogenic T cells to promote T1D pathogenesis. Disrupting B cell APC function prevents T1D in mouse models and has shown promise in clinical trials. Autoantigen-specific B cells thus hold potential as sophisticated T1D biomarkers and therapeutic targets...
April 1, 2024: Antibodies
https://read.qxmd.com/read/38649894/arginine-linked-hpv-associated-e7-displaying-bacteria-derived-outer-membrane-vesicles-as-a-potent-antigen-specific-cancer-vaccine
#30
JOURNAL ARTICLE
Suyang Wang, Chao-Cheng Chen, Ming-Hung Hu, Michelle Cheng, Hsin-Fang Tu, Ya-Chea Tsai, Jr-Ming Yang, T C Wu, Chuan-Hsiang Huang, Chien-Fu Hung
BACKGROUND: Bacteria-based cancer therapy have demonstrated innovative strategies to combat tumors. Recent studies have focused on gram-negative bacterial outer membrane vesicles (OMVs) as a novel cancer immunotherapy strategy due to its intrinsic properties as a versatile carrier. METHOD: Here, we developed an Human Papillomavirus (HPV)-associated E7 antigen displaying Salmonella-derived OMV vaccine, utilizing a Poly(L-arginine) cell penetrating peptide (CPP) to enhance HPV16 E7 (aa49-67) H-2 Db and OMV affinity, termed SOMV-9RE7...
April 22, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38646723/-68-ga-labeled-epha2-targeted-cyclic-peptide-a-novel-positron-imaging-tracer-for-triple-negative-breast-cancer
#31
JOURNAL ARTICLE
Bin Qu, Xianjun Li, Yuze Ma, Yanzhi Wang, Yeming Han, Guihua Hou, Feng Gao
The absence of better biomarkers currently limits early diagnosis and treatment of triple-negative breast cancer (TNBC). Our previously published study reported that the cyclic-peptide SD01 exhibited specific binding to EphA2 (Ephrin type-A receptor 2) on TNBC. To develop a novel PET imaging agent, we prepared gallium-68 (68 Ga) labeled-DOTA-SD01 and evaluated its specificity and effectiveness through micro PET/CT imaging in a TNBC-bearing mouse model. SD01 and a control linear peptide YSA were conjugated to DOTA and subsequently labeled with 68 Ga, obtaining 68 Ga-DOTA-SD01 and 68 Ga-DOTA-YSA...
April 22, 2024: Dalton Transactions: An International Journal of Inorganic Chemistry
https://read.qxmd.com/read/38643189/phosphoproteomic-analysis-reveals-changes-in-a-raf-related-protein-phosphorylation-in-response-to-toxoplasma-gondii-infection-in-porcine-macrophages
#32
JOURNAL ARTICLE
Dingzeyang Su, Shifan Zhu, Kangzhi Xu, Zhaofeng Hou, Fuxing Hao, Fan Xu, Yifan Lin, Yuyang Zhu, Dandan Liu, Qiangde Duan, Xinjun Zhang, Yuguo Yuan, Jinjun Xu, Jianping Tao
BACKGROUND: Toxoplasma gondii is an obligate intracellular protozoan parasite that causes severe threats to humans and livestock. Macrophages are the cell type preferentially infected by T. gondii in vivo. Protein phosphorylation is an important posttranslational modification involved in diverse cellular functions. A rapidly accelerated fibrosarcoma kinase (A-Raf) is a member of the Raf family of serine/threonine protein kinases that is necessary for MAPK activation. Our previous research found that knockout of A-Raf could reduce T...
April 20, 2024: Parasites & Vectors
https://read.qxmd.com/read/38640722/discovery-of-4-phenyl-1h-indazole-derivatives-as-novel-small-molecule-inhibitors-targeting-the-pd-1-pd-l1-interaction
#33
JOURNAL ARTICLE
Chenglong Xu, Zhiqiang Sun, Xuewen Zhang, Qinru Zang, Zichao Yang, Ling Li, Xixiang Yang, Yueyu He, Zeli Ma, Jianjun Chen
The inhibition of the programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) pathway with small molecules is a promising approach for cancer immunotherapy. Herein, novel small molecules compounds bearing various scaffolds including thiophene, thiazole, tetrahydroquinoline, benzimidazole and indazole were designed, synthesized and evaluated for their inhibitory activity against the PD-1/PD-L1 interaction. Among them, compound Z13 exhibited the most potent activity with IC50 of 189.6 nM in the homogeneous time-resolved fluorescence (HTRF) binding assay...
April 16, 2024: Bioorganic Chemistry
https://read.qxmd.com/read/38640016/memo1-binds-iron-and-modulates-iron-homeostasis-in-cancer-cells
#34
JOURNAL ARTICLE
Natalia Dolgova, Eva-Maria E Uhlemann, Michal T Boniecki, Frederick S Vizeacoumar, Anjuman Ara, Paria Nouri, Martina Ralle, Marco Tonelli, Syed A Abbas, Jaala Patry, Hussain Elhasasna, Andrew Freywald, Franco Vizeacoumar, Oleg Y Dmitriev
Mediator of ERBB2-driven Cell Motility 1 (MEMO1) is an evolutionary conserved protein implicated in many biological processes; however, its primary molecular function remains unknown. Importantly, MEMO1 is overexpressed in many types of cancer and was shown to modulate breast cancer metastasis through altered cell motility. To better understand the function of MEMO1 in cancer cells, we analyzed genetic interactions of MEMO1 using gene essentiality data from 1028 cancer cell lines and found multiple iron-related genes exhibiting genetic relationships with MEMO1...
April 19, 2024: ELife
https://read.qxmd.com/read/38633249/early-b-cell-transcriptomic-markers-of-measles-specific-humoral-immunity-following-a-3-rd-dose-of-mmr-vaccine
#35
JOURNAL ARTICLE
Iana H Haralambieva, Jun Chen, Huy Quang Quach, Tamar Ratishvili, Nathaniel D Warner, Inna G Ovsyannikova, Gregory A Poland, Richard B Kennedy
B cell transcriptomic signatures hold promise for the early prediction of vaccine-induced humoral immunity and vaccine protective efficacy. We performed a longitudinal study in 232 healthy adult participants before/after a 3rd dose of MMR (MMR3) vaccine. We assessed baseline and early transcriptional patterns in purified B cells and their association with measles-specific humoral immunity after MMR vaccination using two analytical methods ("per gene" linear models and joint analysis). Our study identified distinct early transcriptional signatures/genes following MMR3 that were associated with measles-specific neutralizing antibody titer and/or binding antibody titer...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38631707/germline-homozygosity-and-allelic-imbalance-of-hla-i-are-common-in-esophagogastric-adenocarcinoma-and-impair-the-repertoire-of-immunogenic-peptides
#36
JOURNAL ARTICLE
Maria Alejandra Garcia-Marquez, Martin Thelen, Eugen Bauer, Lukas Maas, Kerstin Wennhold, Jonas Lehmann, Diandra Keller, Miloš Nikolić, Julie George, Thomas Zander, Wolfgang Schröder, Philipp Müller, Ali M Yazbeck, Christiane Bruns, Roman Thomas, Birgit Gathof, Alexander Quaas, Martin Peifer, Axel M Hillmer, Michael von Bergwelt-Baildon, Hans Anton Schlößer
BACKGROUND: The individual HLA-I genotype is associated with cancer, autoimmune diseases and infections. This study elucidates the role of germline homozygosity or allelic imbalance of HLA-I loci in esophago-gastric adenocarcinoma (EGA) and determines the resulting repertoires of potentially immunogenic peptides. METHODS: HLA genotypes and sequences of either (1) 10 relevant tumor-associated antigens (TAAs) or (2) patient-specific mutation-associated neoantigens (MANAs) were used to predict good-affinity binders using an in silico approach for MHC-binding (www...
April 17, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38631156/in-depth-structure-function-profiling-of-the-complex-formation-between-clotting-factor-viii-and-heme
#37
JOURNAL ARTICLE
Marie-T Hopp, Deniz Ugurlar, Behnaz Pezeshkpoor, Arijit Biswas, Anuradha Ramoji, Ute Neugebauer, Johannes Oldenburg, Diana Imhof
BACKGROUND AND AIMS: Blood disorders, such as sickle cell disease, and other clinical conditions are often accompanied by intravascular hemolytic events along with the development of severe coagulopathies. Hemolysis, in turn, leads to the accumulation of Fe(II/III)-protoporphyrin IX (heme) in the intravascular compartment, which can trigger a variety of proinflammatory and prothrombotic reactions. As such, heme binding to the blood coagulation proteins factor VIII (FVIII), fibrinogen, and activated protein C with functional consequences has been demonstrated earlier...
April 13, 2024: Thrombosis Research
https://read.qxmd.com/read/38630694/reducing-target-binding-affinity-improves-the-therapeutic-index-of-anti-met-antibody-drug-conjugate-in-tumor-bearing-animals
#38
JOURNAL ARTICLE
Amita Datta-Mannan, Hiuwan Choi, Zhaoyan Jin, Ling Liu, Jirong Lu, David J Stokell, Anthony T Murphy, Kenneth W Dunn, Michelle M Martinez, Yiqing Feng
Many oncology antibody-drug conjugates (ADCs) have failed to demonstrate efficacy in clinic because of dose-limiting toxicity caused by uptake into healthy tissues. We developed an approach that harnesses ADC affinity to broaden the therapeutic index (TI) using two anti-mesenchymal-epithelial transition factor (MET) monoclonal antibodies (mAbs) with high affinity (HAV) or low affinity (LAV) conjugated to monomethyl auristatin E (MMAE). The estimated TI for LAV-ADC was at least 3 times greater than the HAV-ADC...
2024: PloS One
https://read.qxmd.com/read/38630135/intratumor-injection-of-bcg-ag85a-high-affinity-peptides-enhanced-anti-tumor-efficacy-in-ppd-positive-melanoma
#39
JOURNAL ARTICLE
Lanqun Qin, Guiying Zhang, Yirong Wu, Yueling Yang, Zhengyun Zou
As one of the scheduled immunization vaccines worldwide, virtually all individuals have been vaccinated with BCG vaccine. In order to verify the hypothesis that delivering BCG high-affinity peptides to tumor areas could activate the existing BCG memory T cells to attack tumor, we firstly predicted the HLA-A*0201 high-affinity peptides of BCG Ag85A protein (KLIANNTRV, GLPVEYLQV), and then, A375 melanoma cells and HLA-A*0201 PBMCs (from PPD-positive adults) were added to co-incubated with the predicted peptides in vitro...
April 17, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38629440/synthesis-in-vitro-and-in-silico-anticancer-evaluation-of-novel-pyridin-2-yl-estra-1-3-5-10-triene-derivatives
#40
JOURNAL ARTICLE
Milica Z Stevanović, Sofija S Bekić, Edward T Petri, Andjelka S Ćelić, Dimitar S Jakimov, Marija N Sakač, Ivana Z Kuzminac
Aim: The aim of this study was the synthesis of steroid compounds with heterocyclic rings and good anticancer properties. Materials & methods: The synthesis, in silico and in vitro anticancer testing of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives was performed. Results: All synthesized compounds have shown promising results for, antiproliferative activity, relative binding affinities for the ligand binding domains of estrogen receptors α, β and androgen receptor, aromatase binding potential, and inhibition of AKR1C3 enzyme...
April 17, 2024: Future Medicinal Chemistry
keyword
keyword
16362
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.